Kalisiak; Jaroslaw
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kalisiak; Jaroslaw.The latest application filed is for "substituted tetrahydropyrans as ccr2 modulators".
Company Profile
22.21.28
- Kalisiak; Jaroslaw - Mountain View CA
- Kalisiak; Jaroslaw - San Diego CA
Patent Activity
| Patent | Date |
|---|---|
| Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2.alpha. Grant 11,407,712 - Beatty , et al. August 9, 2 | 2022-08-09 |
| Substituted Tetrahydropyrans As Ccr2 Modulators App 20220153733 - FAN; Junfa ; et al. | 2022-05-19 |
| Inhibitors of CD73-mediated immunosuppression Grant 11,267,845 - Kalisiak , et al. March 8, 2 | 2022-03-08 |
| Inhibitors Of Arg1 And/or Arg2 App 20220016143 - BEATTY; Joel ; et al. | 2022-01-20 |
| Inhibitors Of Cxcr2 App 20220009911 - CHEN; Xi ; et al. | 2022-01-13 |
| Modulators Of Chemokine Receptors App 20220009912 - CHEN; Xi ; et al. | 2022-01-13 |
| Modulators Of 5'-nucleotidase, Ecto And The Use Thereof App 20210371449 - DEBIEN; Laurent Pierre Paul ; et al. | 2021-12-02 |
| Tetralin And Tetrahydroquinoline Compounds As Inhibitors Of Hif-2alpha App 20210317079 - BEATTY; Joel Worley ; et al. | 2021-10-14 |
| Inhibitors of adenosine 5'-nucleotidase Grant 11,058,704 - Debien , et al. July 13, 2 | 2021-07-13 |
| Inhibitors of CXCR2 Grant 11,040,960 - Chen , et al. June 22, 2 | 2021-06-22 |
| Modulators of 5'-nucleotidase, ecto and the use thereof Grant 11,001,603 - Debien , et al. May 11, 2 | 2021-05-11 |
| Modulators of chemokine receptors Grant 10,988,464 - Chen , et al. April 27, 2 | 2021-04-27 |
| Modulators of 5'-nucleotidase, ecto and the use thereof Grant 10,981,944 - Debien , et al. April 20, 2 | 2021-04-20 |
| Arginase Inhibitors App 20210002306 - FOLEY; Corinne Nicole ; et al. | 2021-01-07 |
| Modulators Of 5'-nucleotidase, Ecto And The Use Thereof App 20210002322 - DEBIEN; Laurent Pierre Paul ; et al. | 2021-01-07 |
| Parenterally Administered Immune Enhancing Drugs App 20200405629 - JAEN; Juan Carlos ; et al. | 2020-12-31 |
| PROCESSES AND INTERMEDIATES IN THE PREPARATION OF C5aR ANTAGONISTS App 20200354320 - FAN; Pingchen ; et al. | 2020-11-12 |
| CCR6 compounds Grant 10,786,494 - Dairaghi , et al. September 29, 2 | 2020-09-29 |
| Inhibitors Of Adenosine 5'-nucleotidase App 20200222441 - DEBIEN; Laurent Pierre Paul ; et al. | 2020-07-16 |
| Inhibitors Of Cxcr2 App 20200140418 - CHEN; Xi ; et al. | 2020-05-07 |
| Substituted Tetrahydropyrans As Ccr2 Modulators App 20200121688 - FAN; Junfa ; et al. | 2020-04-23 |
| Inhibitors Of Cd73-mediated Immunosuppression App 20200062797 - KALISIAK; Jaroslaw ; et al. | 2020-02-27 |
| Blood brain barrier-penetrating oximes for cholinesterase reactivation Grant 10,570,088 - Cashman , et al. Feb | 2020-02-25 |
| Modulators Of Chemokine Receptors App 20200039969 - CHEN; Xi ; et al. | 2020-02-06 |
| Processes and intermediates in the preparation of C5aR antagonists Grant 10,532,982 - Fan , et al. Ja | 2020-01-14 |
| Substituted tetrahydropyrans as CCR2 modulators Grant 10,464,934 - Fan , et al. No | 2019-11-05 |
| Modulators Of 5'-nucleotidase, Ecto And The Use Thereof App 20190309010 - DEBIEN; Laurent Pierre Paul ; et al. | 2019-10-10 |
| PROCESSES AND INTERMEDIATES IN THE PREPARATION OF C5aR ANTAGONISTS App 20190276402 - FAN; Pingchen ; et al. | 2019-09-12 |
| Inhibitors of CXCR2 Grant 10,370,363 - Chen , et al. | 2019-08-06 |
| Modulators of chemokine receptors Grant 10,336,736 - Chen , et al. | 2019-07-02 |
| Ccr6 Compounds App 20190167659 - DAIRAGHI; Daniel ; et al. | 2019-06-06 |
| Processes and intermediates in the preparation of C5aR antagonists Grant 10,266,492 - Fan , et al. | 2019-04-23 |
| Modulators of 5'-nucleotidase, ecto and the use thereof Grant 10,239,912 - Debien , et al. | 2019-03-26 |
| CCR6 compounds Grant 10,117,865 - Dairaghi , et al. November 6, 2 | 2018-11-06 |
| Inhibitors Of Cxcr2 App 20180170916 - CHEN; Xi ; et al. | 2018-06-21 |
| Modulators Of Chemokine Receptors App 20180141934 - CHEN; Xi ; et al. | 2018-05-24 |
| Ccr6 Compounds App 20180092902 - DAIRAGHI; Daniel ; et al. | 2018-04-05 |
| Substituted Tetrahydropyrans As Ccr2 Modulators App 20180086756 - FAN; Junfa ; et al. | 2018-03-29 |
| PROCESSES AND INTERMEDIATES IN THE PREPARATION OF C5aR ANTAGONISTS App 20180072668 - FAN; Pingchen ; et al. | 2018-03-15 |
| Blood Brain Barrier-Penetrating Oximes for Cholinesterase Reactivation App 20170349538 - Cashman; John R. ; et al. | 2017-12-07 |
| Modulators of chemokine receptors Grant 9,834,545 - Chen , et al. December 5, 2 | 2017-12-05 |
| Inhibitors of CXCR2 Grant 9,809,581 - Chen , et al. November 7, 2 | 2017-11-07 |
| CCR6 compounds Grant 9,795,599 - Dairaghi , et al. October 24, 2 | 2017-10-24 |
| Substituted tetrahydropyrans as CCR2 modulators Grant 9,783,540 - Fan , et al. October 10, 2 | 2017-10-10 |
| Modulators Of 5'-nucleotidase, Ecto And The Use Thereof App 20170267710 - DEBIEN; Laurent Pierre Paul ; et al. | 2017-09-21 |
| Processes and intermediates in the preparation of C5aR antagonists Grant 9,745,268 - Fan , et al. August 29, 2 | 2017-08-29 |
| Modulators Of Chemokine Receptors App 20170144997 - CHEN; Xi ; et al. | 2017-05-25 |
| Inhibitors Of Cxcr2 App 20170144996 - CHEN; Xi ; et al. | 2017-05-25 |
| Ccr2 Modulators App 20160340356 - Fan; Junfa ; et al. | 2016-11-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 